Ischemia-reperfusion reduces the negative functional effects of
cyclic GMP in cardiac myocytes. In this study, we tested the hypothesis that upregulation of hypoxic inducible factor-1 (HIF-1) would improve the actions of
cyclic GMP signaling following simulated
ischemia-reperfusion. HIF-1 alpha was increased with
deferoxamine (150 mg/kg for 2 days). Rabbit cardiac myocytes were subjected to simulated
ischemia [15 min 95% N(2)-5% CO(2)] and reperfusion [reoxygenation] to produce myocyte stunning. Cell function was measured utilizing a video-edge detector. Shortening was examined at baseline and after
brain natriuretic peptide (BNP, 10(-8), 10(-7)M) or S-nitroso-N-acetyl-
penicillamine (SNAP, 10(-6), 10(-5)M) followed by
KT5823 (
cyclic GMP protein kinase inhibitor, 10(-6)M).
Kinase activity was measured via a
protein phosphorylation assay. Under control conditions, BNP (-30%) and SNAP (-41%) reduced percent shortening, while
KT5823 partially restored function (+18%).
Deferoxamine treated control myocytes responded similarly. In stunned myocytes, BNP (-21%) and SNAP (-25%) reduced shortening less and
KT5823 did not increase function (+2%).
Deferoxamine increased the effects of BNP (-38%) and SNAP (-41%) in stunning and restored the effects of
KT5823 (+12%). The
cyclic GMP protein kinase increased phosphorylation of several
proteins in control HIF-1 +/- cells. Phosphorylation was reduced in stunned cells and was restored in
deferoxamine treated stunned cells. This study demonstrated that simulated
ischemia-reperfusion reduced the negative functional effects of increasing
cyclic GMP and this was related to reduced effects of the
cyclic GMP protein kinase. Increased HIF-1 alpha protects the functional effects of
cyclic GMP thorough maintenance of
cyclic GMP protein kinase activity after ischemic-reperfusion.